Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

transcreation

- PMLiVE

Shionogi to acquire Qpex Biopharma for approximately $140m

The deal signifies a notable expansion to the Japanese drugmaker’s antimicrobial pipeline

- PMLiVE

FDA approves UCB’s Rystiggo to treat generalised myasthenia gravis

The rare autoimmune disease has a global prevalence of 100 to 350 cases per every one million people

- PMLiVE

Swordfish Advertising promotes Perry and Johnston to director roles

Nina Perry will be serving as client services director and Hannah Johnston as business development director

- PMLiVE

Sanofi’s amlitelimab shows promise in phase 2b atopic dermatitis trial

The inflammatory skin disease affects an estimated 16.5 million adults in the US

- PMLiVE

It’s the Era of Outcomes at ERA 2023

The Medscape team has bid farewell to the beautiful city of Milano, Italy and our European nephrology colleagues. The team was thrilled to meet up with so many ground-breaking clinicians,...

Medscape Education

- PMLiVE

The goldfish principle: making sense of persuasive communication

By Susan Walkley

- PMLiVE

Using knowledge graphs to discover powerful new insights

Looking at how multidimensional knowledge graphs work and their potential within the life sciences industry

- PMLiVE

Pfizer’s Litfulo approved by FDA as first treatment for adolescents with severe alopecia areata

Almost 20% of patients with the autoimmune disease are diagnosed before the age of 18

- PMLiVE

Sanofi and Sobi’s haemophilia A treatment shows effective bleed protection in children

Current factor VIII therapies usually require patients to receive treatment multiple times a week

- PMLiVE

International Respiratory Coalition urges policymakers to help lift disease burden

The societal and economic cost of respiratory disease in Europe is reportedly over €600bn

- PMLiVE

Swordfish Advertising appoints Sarah Rush as new CEO

Rush has been serving as the agency’s client services director since 2019

- PMLiVE

The patient voice

We believe that listening to people's lived experiences are vital components of our work.

Havas Life London

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links